Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
93,42 USD | +1,10 % | +4,90 % | -1,26 % |
03.04. | THE COOPER COMPANIES, INC. : Citigroup bekräftigt seine Kaufempfehlung | ZM |
21.03. | Cooper Companies Insider verkaufte Aktien im Wert von $5,521,230, laut einer aktuellen SEC Einreichung | MT |
Kurzporträt
- Herstellung von Kontaktlinsen (67,8% des Nettoumsatzes; CooperVision): sphärische Linsen (55,3% des Nettoumsatzes), torische Linsen (32,9%) und multifokale Linsen (11,8%) zur Behandlung von Stigmatismus, Alterssichtigkeit, Trockenheit und Augenermüdung;
- Herstellung von chirurgischen Instrumenten (32,2%; CooperSurgical). Die Gruppe bietet auch Dienstleistungen im Bereich der Frauengesundheit an (Diagnostik und Gentests, Fruchtbarkeitsförderung und -behandlung usw.).
Ende Oktober 2022 verfügte die Gruppe über 10 Produktionsstätten in den Vereinigten Staaten (4), dem Vereinigten Königreich (2), Puerto Rico, Kanada, Costa Rica und Ungarn.
Der Nettoumsatz verteilt sich geografisch wie folgt: Vereinigte Staaten (49,5%), Europa (29,8%) und andere (20,7%).
Mitarbeiterzahl: 15 000
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
CooperVision
67,5
%
| 2 243 | 67,8 % | 2 424 | 67,5 % | +8,04 % |
CooperSurgical
32,5
%
| 1 065 | 32,2 % | 1 170 | 32,5 % | +9,80 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
50,4
%
| 1 639 | 49,5 % | 1 812 | 50,4 % | +10,60 % |
Europe
29,0
%
| 987 | 29,8 % | 1 041 | 29,0 % | +5,47 % |
Rest of World, Other Eliminations & Corporate
20,6
%
| 683 | 20,6 % | 740 | 20,6 % | +8,36 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Albert White
CEO | Chief Executive Officer | 54 | 01.04.06 |
Robert Weiss
CHM | Chairman | 77 | 01.01.77 |
Brian Andrews
DFI | Director of Finance/CFO | 45 | 01.04.06 |
Daniel McBride
COO | Chief Operating Officer | 59 | 01.02.05 |
Kim Duncan
IRC | Investor Relations Contact | - | 01.06.18 |
Comptroller/Controller/Auditor | 57 | 01.07.13 | |
Nicholas Khadder
LAW | General Counsel | 50 | 09.08.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Teresa Madden
BRD | Director/Board Member | 67 | 01.12.20 |
Lawrence Kurzius
BRD | Director/Board Member | 66 | 01.12. |
William Kozy
BRD | Director/Board Member | 72 | 01.04.16 |
Cynthia Lucchese
BRD | Director/Board Member | 63 | 01.10.22 |
Albert White
CEO | Chief Executive Officer | 54 | 01.04.06 |
Colleen Jay
BRD | Director/Board Member | 60 | 01.04.16 |
Robert Weiss
CHM | Chairman | 77 | 01.01.77 |
Maria Rivas
BRD | Director/Board Member | 60 | 01.07.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 269 156 284 | 197 677 204 ( 73,44 %) | 70 400 000 ( 26,16 %) | 73,44 % |
Unternehmenskontakt
The Cooper Cos., Inc.
6101 Bollinger Canyon Road Suite 500
94583, San Ramon
+925 460 3600
http://www.coopercos.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
CooperSurgical, Inc.
CooperSurgical, Inc. Medical SpecialtiesHealth Technology CooperSurgical, Inc. develops, manufactures, and markets medical instruments. It offers surgical, clinical and practice based, labor and delivery and critical care. The firm’s surgical products include C-section retractors, hysterectomy/laparoscopic instruments and laparoscopic port-site closures. The company was founded in 1990 and is headquartered in Trumbull, CT. |
Medical Specialties
|
CooperVision, Inc.
CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. |
Medical Specialties
|
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. |
Biotechnology
|
CooperVision Lens Care Ltd.
CooperVision Lens Care Ltd. Electronic ComponentsElectronic Technology Coopervision Lens Care Ltd. develops, manufactures and markets contact lenses and aftercare products. The company was founded in 1985 and is headquartered in Fareham, the United Kingdom. |
Electronic Components
|
CooperVision Nordic AB
| |
CooperVision Ltd.
CooperVision Ltd. Medical DistributorsDistribution Services Part of The Cooper Cos., Inc., CooperVision Ltd. is a British company that specializes in producing soft contact lenses and lens care solutions for various vision conditions, ages, and individual needs. The private company is based in Fareham, UK, and offers a full range of CooperVision contact lens product brands. Additionally, the company provides patient hygiene guides and instructions for use leaflets for their soft contact lenses. Founded in 1980, the company's mission is to help people live brightly by providing daily and monthly soft contact lenses that prioritize health and comfort. |
Medical Distributors
|
CooperVision International Holding Co. LP
CooperVision International Holding Co. LP Financial ConglomeratesFinance Part of The Cooper Cos., Inc., CooperVision International Holding Co. LP is a private company based in St. Michael, Barbados. |
Financial Conglomerates
|
CooperVision Caribbean Corp.
CooperVision Caribbean Corp. Medical SpecialtiesHealth Technology Part of The Cooper Cos., Inc., CooperVision Caribbean Corp. is a Caymanian company that manufactures contact lenses. The private company is based in George Town, Cayman Islands. |
Medical Specialties
|
TCC Holdings SARL
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-1,26 % | 18,37 Mrd. | |
+12,78 % | 96,65 Mrd. | |
+11,70 % | 39,49 Mrd. | |
-13,68 % | 2,42 Mrd. | |
-10,21 % | 1,52 Mrd. | |
+24,72 % | 1,2 Mrd. | |
-33,16 % | 772 Mio. | |
-35,31 % | 739 Mio. | |
-7,40 % | 658 Mio. | |
+27,27 % | 516 Mio. |
- Börse
- Aktien
- A402VX Aktie
- Unternehmen The Cooper Companies, Inc.